BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 25690730)

  • 1. NF-κB in cancer therapy.
    Li F; Zhang J; Arfuso F; Chinnathambi A; Zayed ME; Alharbi SA; Kumar AP; Ahn KS; Sethi G
    Arch Toxicol; 2015 May; 89(5):711-31. PubMed ID: 25690730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classic and Novel Signaling Pathways Involved in Cancer: Targeting the NF-κB and Syk Signaling Pathways.
    Tang C; Zhu G
    Curr Stem Cell Res Ther; 2019; 14(3):219-225. PubMed ID: 30033874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression.
    Bassères DS; Baldwin AS
    Oncogene; 2006 Oct; 25(51):6817-30. PubMed ID: 17072330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear factor-kappaB activation: from bench to bedside.
    Sethi G; Sung B; Aggarwal BB
    Exp Biol Med (Maywood); 2008 Jan; 233(1):21-31. PubMed ID: 18156302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NF-kappaB in cancer--a friend turned foe.
    Ravi R; Bedi A
    Drug Resist Updat; 2004 Feb; 7(1):53-67. PubMed ID: 15072771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear factor-kappa B and cancer: its role in prevention and therapy.
    Bharti AC; Aggarwal BB
    Biochem Pharmacol; 2002 Sep; 64(5-6):883-8. PubMed ID: 12213582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF-kappaB as a potential molecular target for cancer therapy.
    Lee CH; Jeon YT; Kim SH; Song YS
    Biofactors; 2007; 29(1):19-35. PubMed ID: 17611291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The NF-kappaB/IkappaB signaling system: a molecular target in breast cancer therapy.
    Wu JT; Kral JG
    J Surg Res; 2005 Jan; 123(1):158-69. PubMed ID: 15652965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NF-κB and the link between inflammation and cancer.
    DiDonato JA; Mercurio F; Karin M
    Immunol Rev; 2012 Mar; 246(1):379-400. PubMed ID: 22435567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NF-κB Signaling Pathway Inhibitors as Anticancer Drug Candidates.
    de Castro Barbosa ML; da Conceicao RA; Fraga AGM; Camarinha BD; de Carvalho Silva GC; Lima AGF; Cardoso EA; de Oliveira Freitas Lione V
    Anticancer Agents Med Chem; 2017; 17(4):483-490. PubMed ID: 27481554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ganoderic acids suppress growth and angiogenesis by modulating the NF-κB signaling pathway in breast cancer cells.
    Li F; Wang Y; Wang X; Li J; Cui H; Niu M
    Int J Clin Pharmacol Ther; 2012 Oct; 50(10):712-21. PubMed ID: 22762853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of NF-kappaB in lymphoid malignancies.
    Packham G
    Br J Haematol; 2008 Oct; 143(1):3-15. PubMed ID: 18573107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear transcription factor-kappaB as a target for cancer drug development.
    Garg A; Aggarwal BB
    Leukemia; 2002 Jun; 16(6):1053-68. PubMed ID: 12040437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of NF-kappaB in health and disease: mechanisms and therapeutic potential.
    Wong ET; Tergaonkar V
    Clin Sci (Lond); 2009 Mar; 116(6):451-65. PubMed ID: 19200055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockage of interleukin-6 signaling with 6-amino-4-quinazoline synergistically induces the inhibitory effect of bortezomib in human U266 cells.
    Park J; Ahn KS; Bae EK; Kim BS; Kim BK; Lee YY; Yoon SS
    Anticancer Drugs; 2008 Sep; 19(8):777-82. PubMed ID: 18690088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NF-kappaB: a stress-regulated switch for cell survival.
    Piva R; Belardo G; Santoro MG
    Antioxid Redox Signal; 2006; 8(3-4):478-86. PubMed ID: 16677091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
    Zerbini LF; Wang Y; Cho JY; Libermann TA
    Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel approaches to target NF-κB and other signaling pathways in cancer stem cells.
    Ukaji T; Umezawa K
    Adv Biol Regul; 2014 Sep; 56():108-15. PubMed ID: 25128192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the NF-κB pathway in prostate cancer: a promising therapeutic approach?
    Verzella D; Fischietti M; Capece D; Vecchiotti D; Del Vecchio F; Cicciarelli G; Mastroiaco V; Tessitore A; Alesse E; Zazzeroni F
    Curr Drug Targets; 2016; 17(3):311-20. PubMed ID: 26343112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear factor-kappaB: the enemy within.
    Aggarwal BB
    Cancer Cell; 2004 Sep; 6(3):203-8. PubMed ID: 15380510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.